InMed Pharmaceuticals (INM) Gross Margin Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Gross Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.56 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,900.00 |
| Sep 30, 2025 | -302.00 |
| Jun 30, 2025 | 787.00 |
| Mar 31, 2025 | -1,076.00 |
| Dec 31, 2024 | 1,532.00 |
| Sep 30, 2024 | 3,666.00 |
| Jun 30, 2024 | -3,163.00 |
| Mar 31, 2024 | 607.00 |
| Dec 31, 2023 | -178.00 |
| Sep 30, 2023 | 15,542.00 |
| Jun 30, 2023 | 1,944.00 |
| Mar 31, 2023 | -1,176.00 |
| Dec 31, 2022 | -1,416.00 |